Volati divests NaturaMed Pharma and closes the Consumer business area
Volati has entered into an agreement and sold all of the shares in NaturaMed Pharma (“NMP”) to Vision Healthcare. The transaction is taking place at an estimated enterprise value of EUR 6 million and is expected to generate a capital loss of approximately SEK 95 million and a positive liquidity effect of approximately SEK 55 million for Volati. In connection with the transaction, Volati is closing the Consumer business area. NMP is one of the Nordic region’s leading suppliers of nutritional supplements via subscription. Sales are made directly to consumers in Norway, Finland and Sweden.